Current trends in local injection therapy of degenerative-dystrophic diseases of the musculoskeletal system
https://doi.org/10.51793/OS.2024.27.7.006
Abstract
Background. Modern preparations – hyaluronic acid-based synovial fluid prostheses significantly help to improve the results of treatment of deforming osteoarthritis and diseases of periarticular tissues. Cartilage deficiency, degenerative changes in the surrounding soft tissues (tendons of rotator cuff muscles) require specific pathogenetic therapy. Several minimally invasive approaches exist to address these uncommon complications, which mainly consist of intra-articular injections of molecules such as hyaluronic acid. In preclinical and clinical studies, preparations of low molecular weight hyaluronic acids have been found to have, in addition to their mechanical positive properties (viscoinduction), also significant anti-inflammatory and analgesic properties.
Objective. Improving the results of conservative treatment of patients with degenerative-dystrophic diseases of the musculoskeletal system. Materials and methods. The authors present a perfect method of complex conservative treatment using modern trends in local injection therapy, developed to improve the quality of life of patients. 3 clinical examples are considered. The effectiveness of this technique has been proven.
Results. The use of local injection therapy using various types of hyaluronic acid as part of the complex conservative treatment of degenerative and dystrophic diseases of the musculoskeletal system significantly improved the effectiveness of treatment, increasing the mechanical, analgesic and anti-inflammatory effect.
Conclusion. The developed scheme of complex conservative therapy of degenerative-dystrophic diseases of the musculoskeletal system using local injection therapy of various forms of hyaluronic acid helps to improve treatment results and improves the quality of life of the patient.
About the Authors
S. D. Sirazitdinov
Kazan State Medical Academy; Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan
Россия
Россия
Sayar D. Sirazitdinov - orthopedic traumatologist, Head of the Traumatology Department of the Consultative Polyclinic of the Republican Scientific and Practical Center for Traumatology, Senior researcher of the Research Department, State Autonomous Healthcare Institution Republican Clinical Hospital of the Republic of Tatarstan; Assistant of the Department of Traumatology and Orthopedics, Kazan State Medical Academy – branch of the Federal State Budgetary Educational Institution of Additional Professional Education Russian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federation.
138 Orenburg tract, Kazan, 420064; 36 Butlerova str., Kazan, 420012
I. O. Pankov
Kazan State Medical Academy; Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan
Россия
Россия
Igor O. Pankov - Dr. of Sci. (Med.), Professor, Head of the Department of Traumatology and Orthopedics, Kazan State Medical Academy – branch of the Federal State Budgetary Educational Institution of Additional Professional Education Russian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federation; Chief Scientist of the Research Department, State Autonomous Healthcare Institution Republican Clinical Hospital of the Republic of Tatarstan.
36 Butlerova str., Kazan, 420012; 138 Orenburg tract, Kazan, 420064
References
1. Bialik V. E., Makarov M. A., Bialik E. I., Makarov S. A., Nesterenko V. A., Nurmukhametov M. R. Comparing the efficacy of hyaluronic acid products with various molecular weights as mono and combined with chondroitin sulfate regimens in treatment of patients with stage I-III knee osteoarthritis. Nauchno-prakticheskaja revmatologija. 2020; 58 (5): 560-569. (In Russ.) https://doi.org/10.47360/1995-4484-2020-560-569.
2. Karateev A. E. Hyaluronic acid in rheumatic disorders of the periarticular soft tissues: a brief descriptive review. Sovremennaya Revmatologiya. 2022; 16 (5): 88-93. (In Russ.) https://doi.org/10.14412/1996-7012-2022-5-88-93.
3. Nesterenko V. A., Byalik E. I., Makarov M. A., et al. Evaluation of the effectiveness of intra-articular administration of highly purified hyaluronic acid in knee osteoarthritis in real clinical practice. Sovremennaya Revmatologiya. 2021;15 (5): 57-61. (In Russ.) https://doi.org/10.14412/1996-7012-2021-5-57-61.
4. Olyunin Yu. A., Nikishina N. Yu. Osteoarthritis: Key elements in its pathogenesis and current agents for pathogenetic therapy. Sovremennaya Revmatologiya. 2017; 11 (3): 121-128. (In Russ.)
5. Olyunin Yu. A., Schendrigin I. N. Intra-articular injections in the treatment of osteoarthritis. Sovremennaya Revmatologiya. 2022; 16(1): 97-102. (In Russ.) https://doi.org/10.14412/1996-7012-2022-1-97-102.
6. Altman R., Manjoo A., Fierlinger A., et al. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015; :16, 321. https://doi.org/10.1186/s12891-015-0775-z.
7. Altman R., Lim S., Steen R. G., Dasa V. Hyaluronic Acid Injections Are Associated with Delay of Total Knee Replacement Surgery in Patients with Knee Osteoarthritis: Evidence from a Large U.S. Health Claims Database. PLoS One. 2015; 10 (12): e0145776.
8. Bannuru R. R., Osani M. C., Vaysbrot E. E., et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019; 27 (11): 1578-1589. DOI: 10.1016/j.joca.2019.06.011.
9. Bruyere O., Honvo G., Veronese N., et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019; 49 (3): 337-350. DOI: 10.1016/j.semarthrit.2019.04.008.
10. Dasa V., Lim S., Heeckt P. Real-World Evidence for Safety and Effectiveness of Repeated Courses of Hyaluronic Acid Injections on the Time to Knee Replacement Surgery. Am J Orthop (Belle Mead NJ). 2018; 47 (7). DOI: 10.12788/ajo.2018.0058.
11. Ghosh P., Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum. 2002; 32 (1): 10-37. DOI: 10.1053/sarh.2002.33720.
12. Gotoh S., Onaya J., Abe M., et al. Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. Ann Rheum Dis. 1993; 52 (11): 817-822. DOI: 10.1136/ard.52.11.817.
13. James S. L., Abate D., Abate K. H., et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392 (10159): 1789-1858. DOI: 10.1016/S0140-6736(18)32279-7.
14. Migliore A., Frediani B., Gigliucci G., et al. One-year follow-up showing effects of single intra-articular injection of hyaluronic acid (1,500-2,000 kDa) in symptomatic knee osteoarthritis. J Biol Regul Homeost Agents. 2018; 32 (6): 1433-1441.
15. Molnar V., Matisic V., Kodvanj I., et al. Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis. Int J Mol Sci. 2021; 22 (17): 9208. DOI: 10.3390/ijms22179208.
16. Li Y., Xie W., Xiao W., Dou D. Progress in osteoarthritis research by the National Natural Science Foundation of China. Bone Res. 2022; 10 (1): 41. DOI: 10.1038/s41413-022-00207-y.
17. Sharma L. Osteoarthritis of the Knee. N Engl J Med. 2021; 384 (1): 51-59. DOI: 10.1056/NEJMcp1903768.
Review
For citations:
Sirazitdinov S.D., Pankov I.O. Current trends in local injection therapy of degenerative-dystrophic diseases of the musculoskeletal system. Lechaschi Vrach. 2024;(7):41-47. (In Russ.) https://doi.org/10.51793/OS.2024.27.7.006
Views:
93
JATS XML
Email this article 
